CHALLENGER LIMITED (CGF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGF - CHALLENGER LIMITED

Year End: June
GICS Industry Group : Diversified Financials
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Challenger Ltd is an Australian financial company that specialises in superannuation and annuities. It claims to be Australia's largest guaranteed income provider. Founded in 1985 it was listed in 2003.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$5.93

21 Jan
2022

-0.160

OPEN

$6.04

-2.63%

HIGH

$6.08

1,404,322

LOW

$5.90

TARGET
$6.271 5.8% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AMP . ASX . BLA . PDL . GBST . HGG . IFL . IRE . MFG . PPS . PPT . PTM . CVW . JHG . CL1 . ENN . KAM . KSL . BVS . PNI . MOE . NWL . LNK . GBT . HUB . NGI . GDG . AEF . PAC . MQG . MAF . MAI . GDC . TDI . RZI . HMC .
FNARENA'S MARKET CONSENSUS FORECASTS
CGF: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 88.2 39.7 xxx
DPS (cps) xxx 20.0 22.3 xxx
EPS Growth xxx N/A - 55.0% xxx
DPS Growth xxx 14.3% 11.4% xxx
PE Ratio xxx N/A 14.9 xxx
Dividend Yield xxx N/A 3.8% xxx
Div Pay Ratio(%) xxx 22.7% 56.1% xxx

Dividend yield today if purchased 3 years ago: 2.61%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.37

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 30/08 - ex-div 10.5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx88.2
DPS All xxxxxxxxxxxxxxx20.0
Sales/Revenue xxxxxxxxxxxxxxx3,031.8 M
Book Value Per Share xxxxxxxxxxxxxxx568.8
Net Operating Cash Flow xxxxxxxxxxxxxxx2,576.6 M
Net Profit Margin xxxxxxxxxxxxxxx19.54 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx16.74 %
Return on Invested Capital xxxxxxxxxxxxxxx10.48 %
Return on Assets xxxxxxxxxxxxxxx2.02 %
Return on Equity xxxxxxxxxxxxxxx16.74 %
Return on Total Capital xxxxxxxxxxxxxxx9.51 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx2,499.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.1

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

14/10/2021

3

Neutral

$6.25

5.40%

UBS observes Challenger's fund and life flows were reasonably resilient in the first quarter. Total life flows of $600m delivered book growth of 3.4%. Sales were also ahead of the broker's "conservative" expectations.

UBS suspects there is some modest margin pressure, given the composition of flows, but this is likely offset by a re-allocation of assets away from cash and fixed income. The broker retains a Neutral rating and raises the target to $6.25 from $6.10.

FORECAST
UBS forecasts a full year FY22 EPS of 40.00 cents.
UBS forecasts a full year FY23 EPS of 45.00 cents.

Credit Suisse

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

CGF STOCK CHART